4.4 Editorial Material

Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

期刊

HAEMATOLOGICA
卷 93, 期 1, 页码 1-3

出版社

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.12318

关键词

-

资金

  1. Intramural NIH HHS [ZIA HL006012-02, ZIA HL006012-01, ZIA HL006014-01, ZIA HL006014-02] Funding Source: Medline

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Immunology

The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease

Oluwabukola T. Gbotosho, Maria G. Kapetanaki, Gregory J. Kato

Summary: Hemolysis is a common feature in various diseases, resulting in the release of harmful metabolites from hemoglobin and exceeding the capacity of protective mechanisms. In Sickle Cell Disease (SCD), circulating heme plays a significant role in disease progression by promoting oxidative stress and proinflammatory responses.

FRONTIERS IN IMMUNOLOGY (2021)

Letter Hematology

Lactate dehydrogenase to carboxyhemoglobin ratio as a biomarker of heme release to heme processing is associated with higher tricuspid regurgitant jet velocity and early death in sickle cell disease

Annelies J. van Vuren, Caterina P. Minniti, Laurel Mendelsohn, John H. Baird, Gregory J. Kato, Eduard J. van Beers

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Medicine, General & Internal

Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial

James F. Casella, Bruce A. Barton, Julie Kanter, L. Vandy Black, Suvankar Majumdar, Adlette Inati, Yasser Wali, Richard A. Drachtman, Miguel R. Abboud, Yurdanur Kilinc, Beng R. Fuh, Murtadha K. Al-Khabori, Clifford M. Takemoto, Emad Salman, Sharada A. Sarnaik, Nirmish Shah, Claudia R. Morris, Jennifer Keates-Baleeiro, Ashok Raj, Ofelia A. Alvarez, Lewis L. Hsu, Alexis A. Thompson, India Y. Sisler, Betty S. Pace, Suzie A. Noronha, Joseph L. Lasky, Elena Cela de Julian, Kamar Godder, Courtney Dawn Thornburg, Natalie L. Kamberos, Rachelle Nuss, Anne M. Marsh, William C. Owen, Anne Schaefer, Cameron K. Tebbi, Christophe F. Chantrain, Debra E. Cohen, Zeynep Karakas, Connie M. Piccone, Alex George, Jason M. Fixler, Tammuella C. Singleton, Thomas Moulton, Charles T. Quinn, Clarisse Lopes de Castro Lobo, Abdulkareem M. Almomen, Meenakshi Goyal-Khemka, Philip Maes, Marty Emanuele, Rebecca T. Gorney, Claire S. Padgett, Ed Parsley, Shari S. Kronsberg, Gregory J. Kato, Mark T. Gladwin

Summary: The study found that poloxamer 188 did not significantly shorten the duration of vaso-occlusive episodes in children and adults with sickle cell disease. Although there were some differences observed in participants under 16 years old, the overall effect was not significant.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Biochemistry & Molecular Biology

Gene Therapy as the New Frontier for Scikle Cell Disease

Himanshu Garg, Kristina J. Tatiossian, Karsten Peppel, Gregory J. Kato, Eva Herzog

Summary: SCD is a common monogenic disorder caused by a point mutation in the beta-globin gene, making it a prototypical target for precision therapy. Both the mutant beta-globin protein and its downstream pathophysiology are intensively researched pharmacological targets. Recent advances in HSC transplantation and gene therapy platforms have expanded potentially curative options for SCD patients.

CURRENT MEDICINAL CHEMISTRY (2022)

Article Hematology

Exercise-induced changes of vital signs in adults with sickle cell disease

Solomon Johnson, Victor R. Gordeuk, Roberto Machado, J. Simon R. Gibbs, Mariana Hildesheim, Jane A. Little, Gregory J. Kato, Mark T. Gladwin, Mehdi Nouraie

Summary: This study evaluated the predictors and prognostic value of exercise-induced vital sign changes (VSC) during the six-minute walk test (6MWT) in adult sickle cell disease (SCD) patients. The findings showed that increases in heart rate and blood pressure, as well as oxygen desaturation, are common during the 6MWT for SCD patients. Additionally, an increase in systolic blood pressure (SBP) during the 6MWT was associated with improved survival, indicating potential benefits in stroke volume capacity for these patients.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Meeting Abstract Hematology

Targeted Proteomics of Pulmonary Hypertension in Sickle Cell Disease

Varshini Babu, Jane A. Little, Claudia R. Morris, Roberto Machado, J. Simon R. Gibbs, Gregory J. Kato, Victor R. Gordeuk, Mark T. Gladwin, Yingze Zhang, Seyed Mehdi Nouraie

Article Medicine, General & Internal

Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence

Thomas Gentinetta, John D. Belcher, Valerie Bruegger-Verdon, Jacqueline Adam, Tanja Ruthsatz, Joseph Bain, Daniel Schu, Lisa Ventrici, Monika Edler, Hadi Lioe, Kalpeshkumar Patel, Chunsheng Chen, Julia Nguyen, Fuad Abdulla, Ping Zhang, Andreas Wassmer, Meena Jain, Marcel Mischnik, Matthias Pelzing, Kirstee Martin, Roslyn Davis, Svetlana Didichenko, Alexander Schaub, Nathan Brinkman, Eva Herzog, Adrian Zuercher, Gregory M. Vercellotti, Gregory J. Kato, Gerald Hoebarth

Summary: People living with sickle cell disease (SCD) often suffer from acute pain due to blood vessel blockage. This study discovered that hemopexin, a protein found in plasma, can alleviate the symptoms of vaso-occlusion by inhibiting inflammatory reactions and reducing the expression of adhesion proteins. Animal experiments and clinical trials have shown promising results, suggesting that hemopexin could be a potential treatment for SCD.

JOURNAL OF CLINICAL MEDICINE (2022)

Letter Hematology

Safety of liver biopsy in patients with sickle cell related liver disease: A single-center experience

Anusha Vittal, Hawwa Alao, Julian Hercun, Bashar Sharma, Arsalan Khan, Disha Sharma, Wilson Lee, Devika Kapuria, Matthew Hsieh, John Tisdale, Courtney Fitzhugh, David Kleiner, Elliot Levy, Richard Chang, Anna Conrey, Elenita Rivera, Amy Huang, Gil Ben Yakov, Gregory J. Kato, Mark T. Gladwin, Swee Lay Thein, Christopher Koh, Theo Heller

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Review Cell Biology

Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model

Tirthadipa Pradhan-Sundd, Gregory J. Kato, Enrico M. Novelli

Summary: Sickle cell disease is a common genetic disorder that can lead to liver dysfunction, with therapeutic options still not well understood. Animal models have played a crucial role in studying the molecular mechanisms and potential treatments for SCD-related liver diseases.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)

Article Multidisciplinary Sciences

Immunomodulatory actions of a kynurenine-derived endogenous electrophile

Mara Carreno, Maria F. Pires, Steven R. Woodcock, Tomasz Brzoska, Samit Ghosh, Sonia R. Salvatore, Fei Chang, Nicholas K. H. Khoo, Matthew Dunn, Nora Connors, Shuai Yuan, Adam C. Straub, Stacy G. Wendell, Gregory J. Kato, Bruce A. Freeman, Solomon F. Ofori-Acquah, Prithu Sundd, Francisco J. Schopfer, Dario A. Vitturi

Summary: The up-regulation of kynurenine metabolism leads to the production of immunomodulatory Kyn-CKA. In sickle cell disease, increased synthesis of Kyn-CKA inhibits inflammation and protects tissues from damage.

SCIENCE ADVANCES (2022)

Meeting Abstract Hematology

CSL112 Increases Plasma Cholesterol Efflux Capacity and Reduces Erythrocyte Membrane Cholesterol Content in Blood Samples from Patients with Sickle Cell Disease

Svetlana Didichenko, Alexey Navdaev, Moritz Saxenhofer, Stefanie Graeter, Alexander Schaub, Alicia Rovo, Gregory J. Kato, Bronwyn Kingwell

Article Genetics & Heredity

Genetic variants and effect modifiers of QT interval prolongation in patients with sickle cell disease

Mengna Zhang, William B. Hillegass, Xue Yu, Suvankar Majumdar, J. Daryl Pollard, Erin Jackson, Jarrod Knudson, Douglas Wolfe, Gregory J. Kato, Joseph F. Maher, Hao Mei

Summary: This study identified several candidate genetic variants associated with QTc interval prolongation in sickle cell disease (SCD) patients and found serum alanine transaminase (ALT) to be a modifying factor. The association of a CPS1 gene variant in both QTc and JTc duration suggests the involvement of the urea cycle and nitric oxide metabolism in cardiac repolarization in SCD. Larger replication studies are needed to confirm these findings and elucidate the underlying mechanisms.
Meeting Abstract Hematology

Exercise Induced Changes of Vital Signs in Adults with Sickle Cell Disease

Solomon Johnson, Victor R. Gordeuk, Roberto Machado, J. Simon R. Gibbs, Mariana Hildesheim, Jane A. Little, Gregory J. Kato, Mark T. Gladwin, Seyed Mehdi Nouraie

Meeting Abstract Hematology

Prevention of Heme-Induced Human Endothelial Cell Activation By Hemopexin in Vitro

Jacqueline Adam, Thomas Gentinetta, Svetlana Diditchenko, Alexander Schaub, Gregory J. Kato, Nathan Brinkman, Adrian Zuercher

Meeting Abstract Biochemistry & Molecular Biology

Kynurenine-derived Electrophiles: Potential Adaptive Mediators in Sickle Cell Disease

Mara Carreno, Maria Pires, Steven Woodcock, Sonia Salvatore, Gregory Kato, Samit Ghosh, Solomon Ofori-Acquah, Bruce Freeman, Francisco Schopfer, Dario Vitturi

FREE RADICAL BIOLOGY AND MEDICINE (2020)

暂无数据